ArticleAmerican journal of cancer research2011
Nanotechnology for energy-based cancer therapies.
Article in American journal of cancer research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Enhanced cancer therapy with cold-controlled drug release and photothermal warming enabled by one nanoplatform.Biomaterials · 2018Article
- A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents. [Corrected].Nature communications · 2015Article
- Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction.Acta biomaterialia · 2014Article
- A novel implantable glaucoma valve using ferrofluid.PloS one · 2013Article
- Plasmonic nanobubbles rapidly detect and destroy drug-resistant tumors.Theranostics · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To overcome problems of systemic toxicity associated with chemotherapy and enhance treatment resolution of cancer therapies, nanotechnology is increasingly providing many novel approaches, especially to energy-based cancer therapies. Enhancements to treatment targeting, the ability to facilitate combined therapies, and treatment imaging are but a few of the ongoing investigations in this ever growing field. This review briefly explores the modalities of energy-based cancer therapies, how nanotechnology has been allowed for improvements within them, and discusses potential future applications of combined therapies.
Indexed as
Identifiers
21984969PMC3186049What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.